Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide in Severe COVID-19
NCT04652115Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2026
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in coronavirus disease 2019 (COVID-19), sponsored by Brigham and Women's Hospital. Started Jan 2021; status: recruiting.
02
Drugs
defibrotide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04652115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652115.